CD200R1 and head and neck squamous cell carcinoma: These cells could be part of an inhibitory pathway: CD200R activation stimulates the differentiation of T-cells to Treg [39], the numerical increase of Treg in parallel with TIL number has been reported in HPV(+) HNSCC [40].